Metformin (generic), Glucophage Newswire (Page 5)

Metformin (generic), Glucophage Newswire (Page 5)

Comprehensive Real-Time News Feed for Metformin (generic), Glucophage. (Page 5)

Results 81 - 100 of 1,121 in Metformin (generic), Glucophage

  1. ProMetic Life Sciences' (PFSCF) CEO Pierre Laurin on Q2 2016 Results - Earnings Call TranscriptRead the original story w/Photo

    Aug 12, 2016 | Seeking Alpha

    Good day, my name is Steve and I will be your conference operator today. At this time, I would like to welcome everyone to the ProMetic Life Sciences 2016 Second Quarter Results Conference Call.

    Comment?

  2. Stepwise program can reduce diabetes incidenceRead the original story w/Photo

    Aug 12, 2016 | PhysOrg Weblog

    A culturally-tailored stepwise diabetes prevention program can reduce incidence of diabetes among overweight/obese Asian Indian adults, according to a study published online Aug. 8 in Diabetes Care . Mary Beth Weber, Ph.D., M.P.H., from Emory University in Atlanta, and colleagues conducted a randomized trial involving 578 overweight/obese Asian Indian adults with isolated impaired glucose tolerance , isolated impaired fasting glucose , or IFG+IGT.

    Comment?

  3. Metformin use and risk of lactic acidosis in people with diabetes...Read the original story

    Aug 12, 2016 | CiteULike

    Metformin use and risk of lactic acidosis in people with diabetes with and without renal impairment: a cohort study in Denmark and the UK. To assess risk of lactic acidosis among metformin users compared with other glucose-lowering agent users, according to renal function.

    Comment?

  4. Bilirubin contributes to immune suppression after islet transplantsRead the original story w/Photo

    Aug 11, 2016 | PhysOrg Weblog

    A team of researchers has found that doses of bilirubin help provide suppression of the immune response following islet transplantation in mouse models. Bilirubin also significantly decreased islet cell death after the cells had been isolated and undergone nutrient deprivation and hypoxic stress.

    Comment?

  5. Molecular features of biguanides required for targeting of mitochondrial respiratory complexRead the original story w/Photo

    Aug 11, 2016 | PhysOrg Weblog

    The biguanides are a family of drugs with diverse clinical applications. Metformin, a widely used anti-hyperglycemic biguanide, suppresses mitochondrial respiration by inhibiting respiratory complex I. Phenformin, a related anti-hyperglycemic biguanide, also inhibits respiration, but proguanil, which is widely used for the prevention of malaria, does not.

    Comment?

  6. vTv Therapeutics' TTP399 Met Primary Endpoint in Phase IIb Study for Type 2 DiabeticsRead the original story

    Aug 9, 2016 | BioSpace

    Topline results showed achievement of the primary endpoint of statistically significant change from baseline in HbA1c at 6 months of daily administration of 800 mg of TTP399. The reduction in HbA1c was dose-dependent and sustained throughout the duration of the study.

    Comment?

  7. Molecular features of biguanides required for targeting of...Read the original story w/Photo

    Aug 8, 2016 | BioMed Central

    The biguanides are a family of drugs with diverse clinical applications. Metformin, a widely used anti-hyperglycemic biguanide, suppresses mitochondrial respiration by inhibiting respiratory complex I. Phenformin, a related anti-hyperglycemic biguanide, also inhibits respiration, but proguanil, which is widely used for the prevention of malaria, does not.

    Comment?

  8. How technology is changing the way your GP treats youRead the original story w/Photo

    Aug 9, 2016 | PhysOrg Weblog

    Doctors were armed with a stethoscope and thermometer 50 years ago, but new technology means GPs now have a bag full of gadgets to find out what is wrong with patients. There are around 20 different tools that GPs use to diagnose a range of conditions, including ear and eye infections , asthma, diabetes, high blood pressure and cancer.

    Comment?

  9. Gene variant explains differences in diabetes drug responseRead the original story w/Photo

    Aug 9, 2016 | PhysOrg Weblog

    The first results from a large international study of patients taking metformin, the world's most commonly used type 2 diabetes drug, reveal genetic differences among patients that may explain why some respond much better to the drug than others. The insight could ultimately help physicians predict which patients will need higher doses than others to produce the same health effects, or need to be prescribed different drugs altogether.

    Comment?

  10. Plant extract shows kidney-protective potential in obese, study findsRead the original story w/Photo

    Aug 8, 2016 | NutraIngredients

    "The presence of these phytochemicals in Caralluma Fimbriata may be the most likely explanation for its protective effect against HF diet-induced metabolic alterations." A Marco Schmidt/CC BY-SA 2.5 A plant extract has been shown to positively affect complications seen in obese individuals; particularly those linked to the kidney, such as insulin resistance and high blood sugars, a study has shown.

    Comment?

  11. The search for the 'Holy Grail' of human longevityRead the original story w/Photo

    Aug 7, 2016 | The Toronto Star

    Scientists seeking to slow the aging process are focusing on a diabetes drug that has shown some promising signs in the lab. The Fountain of Youth by Lucas Cranach the Elder, circa 1546.

    Comment?

  12. This Long-Term Cardiovascular Study Could Revolutionize the Treatment of Type 2 DiabetesRead the original story w/Photo

    Aug 6, 2016 | The Motley Fool

    It may not incite the same amount of fear as cancer, but diabetes is a growing problem within the United States. According to the 2014 National Diabetes Statistics Report from the Centers for Disease Control and Prevention, some 29.1 million people in the United States have diabetes .

    Comment?

  13. Demystifying menstrual synchrony-women's subjective beliefs about...Read the original story w/Photo

    Aug 5, 2016 | PhysOrg Weblog

    Demystifying Menstrual Synchrony: Women's Subjective Beliefs About Bleeding in Tandem With Other Women , an article recently published in Women's Reproductive Health , addresses the overlooked issue of why many women believe in menstrual synchrony. While there is a substantial body of scientific work on whether or not menstrual synchrony exists, far less work has examined why women believe in menstrual synchrony and the reasons they attribute to its existence.

    Comment?

  14. Adlyxin Gets FDA Approval to Treat Type 2 DiabetesRead the original story w/Photo

    Aug 4, 2016 | Kansas City InfoZine

    Over time, high blood sugar levels can increase the risk for serious complications, including heart disease, blindness and nerve and kidney damage. Adlyxin is a glucagon-like peptide-1 receptor agonist, a hormone that helps normalize blood sugar levels.

    Comment?

  15. Comparison of Clinical Outcomes and Adverse Events Associated With...Read the original story

    Aug 3, 2016 | CiteULike

    Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis. Numerous glucose-lowering drugs are used to treat type 2 diabetes.

    Comment?

  16. A silver lining for type 2 diabetics could help patients with abdominal aortic aneurysmsRead the original story w/Photo

    Aug 2, 2016 | Stanford

    Abdominal aortic aneurysms , or distensions of the aortic artery as it passes through abdomen, aren't a widely talked about form of cardiovascular disease. But each year, more than 200,000 people in the U.S. are diagnosed with an AAA, and these aneurysms represent the 10th leading cause of death among men over 55. If an aneurysm ruptures, it sets off massive internal bleeding that leaves patients with a 50/50 chance of death .

    Comment?

  17. Pros & Cons Of New Type 2 Diabetes DrugsRead the original story w/Photo

    Aug 2, 2016 | CBS Local

    CBS4 CBS4 is now on CBSMiami.com. It's the same great news, weather, and investigations you found on cbs4.com, but we've added a whole new range of great items and features to help you get more out [...] My TV 33 My TV33 is on CBSMiami.comIt's the same great news, weather, and investigations you found on cbs4.com, but we've added a whole new range of great items and features to help you get more out of [...] WQAM Miami's Sports Radio 560 WQAM is South Florida's original sports station.

    Comment?

  18. Sun Pharma to launch diabetes tablet in USRead the original story

    Aug 1, 2016 | Newkerala.com

    Chennai, Aug 2 : Indian drug major Sun Pharmacuetical Industries Ltd on Tuesday said it will launch the generic version of Glumetza, Metformin Hydrochloride tablets - a diabetes drug - soon in the US. The company said in a statement, that one of its subsidiaries got the final approval from the US Food and Drug Administration for its Abbreviated New Drug Application for generic version of Glumetza, Metformin Hydrochloride extended release tablets 500 mg and 1,000 mg.

    Comment?

  19. Discovery sheds light on new strategy to treat some instances of preterm laborRead the original story w/Photo

    Aug 1, 2016 | PhysOrg Weblog

    A new research report appearing in the August 2016 issue of the Journal of Leukocyte Biology reveals a potentially new therapeutic target for preventing or stopping preterm labor. Specifically, using mice, researchers from the United States show that blocking specific cell signaling pathways may reduce the risk of preterm labor caused by the immune system or inflammation, or stop it altogether.

    Comment?

  20. Fighting diabetes lying down?Read the original story w/Photo

    Aug 1, 2016 | PhysOrg Weblog

    Lying down all day can have serious implications - but according to a new study a short stint spent horizontal may be an effective way to fight type 2 diabetes. University of Queensland School of Human Movement and Nutrition Studies researcher Ravin Lal is trialling an External Counterpulsation device which simulates the effects of physical activity.

    Comment?